NYSE$YCBD
cbdMD Inc · Q3 2021 earnings
Q3 2021 earnings · · Investor relations
Briefing
Reported steady year-over-year net sales and earnings of $.02 per share.
cbdMD, Inc. reported net sales of $10.6 million for the third quarter of fiscal 2021, remaining steady year-over-year. The company announced earnings of $.02 per share for the quarter. However, due to product production delays from vendors on new product launches, the company reduced its Q1 fiscal 2022 net sales guidance to a range of $14.9 million to $15.5 million.
- Net sales of $10.6 million remained steady year-over-year.
- Gross profit margin remained strong at approximately 68%, up from 65% in the prior year’s third quarter.
- E-commerce direct-to-consumer net sales were $7.8 million, a decrease of 4.9% from the prior year’s third fiscal quarter.
- Net income attributable to common shareholders was approximately $977,000, or $0.02 per share.
Headline financials
Revenue & EPS history
cbdMD · Revenue · Quarterly
$10.6M
Revenue by segment
cbdMD · $3.8M total across 1 segment · Q2 2026
- E-commerce sales$3.8M—100.0%
Forward guidance
Due to production delays from vendors on new product launches, the company is revising its net sales guidance for the first quarter of fiscal 2022 ending December 31, 2021 from a range of $15.5 million to $16.25 million to a range of $14.9 million to $15.5 million, or 20-25% YOY sales growth for the December, 2021 quarter.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2021
-0.5%
Avg return
Earnings day
-3.1%
Avg return
5 days after
-10.8%
Avg return
30 days after
42%
15 / 36 earnings
Positive
+70.1%
Q2 2020
Best reaction
-22.4%
Q4 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q4 2025 | +0.0% | +5.3% | -38.9% | |
| Q3 2025 | -11.1% | -22.4% | -20.0% | |
| Q2 2026 | -4.0% | -8.2% | -13.2% | |
| Q2 2025 | -4.0% | -8.2% | -13.2% | |
| Q1 2025 | -15.1% | -24.6% | -52.6% | |
| Q4 2024 | -15.7% | -22.1% | +14.4% | |
| Q3 2024 | +3.7% | +2.1% | +7.6% | |
| Q2 2024 | +0.0% | +1.0% | -8.6% | |
| Q1 2024 | -12.3% | -5.5% | -0.7% | |
| Q4 2023 | +7.9% | +6.4% | +17.7% | |
| Q3 2023 | +0.7% | -5.6% | -9.8% | |
| Q2 2023 | -6.9% | -6.0% | -21.6% | |
| Q1 2023 | -5.8% | +1.8% | -28.1% | |
| Q4 2022 | -22.4% | -29.9% | -8.6% | |
| Q3 2022 | -5.9% | -11.6% | -48.4% | |
| Q2 2022 | +8.4% | +28.6% | -31.7% | |
| Q1 2022 | -19.5% | -16.3% | -14.0% | |
| Q4 2021 | +3.5% | +0.9% | -7.1% | |
| Q3 2021 | -5.0% | -7.8% | +3.7% | |
| Q2 2021 | -21.8% | -17.4% | -0.3% | |
| Q1 2021 | +15.2% | -9.2% | -19.4% | |
| Q4 2020 | +15.1% | +6.5% | +6.5% | |
| Q3 2020 | +8.1% | +10.2% | -27.6% | |
| Q2 2020 | +70.1% | +71.1% | +54.6% | |
| Q1 2020 | +2.6% | +0.0% | -40.9% | |
| Q4 2019 | -0.7% | -1.4% | -59.7% | |
| Q3 2019 | -9.4% | -11.6% | -11.4% | |
| Q2 2019 | -3.1% | +0.6% | -2.0% | |
| Q1 2019 | +1.8% | +6.5% | -9.7% | |
| Q4 2018 | -12.4% | -21.1% | +7.2% | |
| Q3 2017 | +14.4% | +1.4% | +13.0% | |
| Q3 2018 | +14.4% | +1.4% | +13.0% | |
| Q2 2017 | -1.2% | -10.2% | -22.3% | |
| Q2 2018 | -1.2% | -10.2% | -22.3% | |
| Q1 2018 | -7.7% | -10.1% | -14.3% | |
| Q4 2017 | +2.9% | +5.3% | +18.6% | |
| Q1 2017 | — | — | — | |
| Q4 2016 | — | — | — | |
| Q3 2016 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro